CNTB: connectbiopharm.com Kompaniya qiymatining sof foydaga nisbati
Connect Biopharma o'zining B2B segmentini kengaytirgan holda, yallig'lanish patologiyalariga qarshi kurashish uchun T-hujayra terapiyalarini ishlab chiqishni kengaytirmoqda. AQSh va Xitoy bozorlaridagi molekulalar uchun kuchli patent himoyasi og'ir surishgan surunkali kasalliklarni davolashda qulay narxlarni kafolatlaydi. Ushbu narxlar grafigi -0.60 miqdoridagi P/E koeffitsiyentini aks ettiradi, kompaniyaning sertifikatlangan laboratoriyalari esa klinik test ma'lumotlarini muntazam ravishda qayta ishlaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_CNTB_-_Connect-Biopharma_-_PE-Multiple "CNTB: Connect Pharma Biznesning o‘zini qoplash muddati 25.09.2023 - 11.11.2026 | 👁️GURU.Markets👁️")
Connect Biopharma Holdings (CNTB) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Connect Biopharma|CNTB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Connect Pharma|CNTB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Connect Biopharma Holdings Limited|CNTB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Connect Biopharma|Tezkor likvidlik ko‘rsatkichi connectbiopharm.com
- foyda va bozor multiplikatorlari tafsilotlari:
CNTB - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Connect Biopharma|CNTB - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Connect Pharma|CNTB - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Connect Biopharma Holdings Limited|CNTB - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Connect Biopharma|CNTB - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi connectbiopharm.com|CNTB - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Connect Biopharma
Kompaniyaning har tomonlama tahlili:connectbiopharm.com CNTB
Connect Biopharma teri va gastrointestinal yallig'lanishlar uchun innovatsion terapiyalarni ishlab chiqishi ulkan investitsiyalarni talab qiladi, bu esa kapital samaradorligini baholashni o'ta muhim qiladi. Kompaniyaning P/E grafigida aks etgan foydaga nisbatan narx ko'rsatkichi biznesning ishlanmalarni monetizatsiya qilish va xarajatlarni bozorga o'tkazish qobiliyatini o'lchaydi, bu esa investorlarga aktivlarning haddan tashqari qiziganini yoki biznesning to'xtab qolganini zudlik bilan aniqlash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Tourmaline (TRML) - Narx-foyda koeffitsiyenti|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati pharming.com (PHAR)|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narx-foyda multiplikatori UPB (Upstream Bio, Inc.)|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|Immunome Bio - Narx-foyda multiplikatori|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|kalvista.com (KALV) - Kapitalizatsiyaning foydaga nisbati|Septerna - P/E multiplikatori|Pieris Pharma (PVLA) - Narx-foyda koeffitsiyenti|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|RIGL: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti ANAB|ATXS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENGN|Narxning foydaga nisbati RAPT (RAPT Therapeutics Inc.)|P/E multiplikatori JBIO (Aerovate Therapeutics)|Biznesning o‘zini qoplash muddati Aclaris Therapeutics, Inc (ACRS)|KYTX - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati tizianalifesciences.com|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati VTYX (Ventyx Biosciences Inc.)|THTX (Theratechnologies Inc) - P/E multiplikatori|AVTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ELDN|P/E multiplikatori agenusbio.com (AGEN)|Narxning foydaga nisbati Climb Bio CLYM|Kompaniya qiymatining sof foydaga nisbati ZURA|ATYR - Narxning foydaga nisbati|Adagene (ADAG) - Narx-foyda koeffitsiyenti|IMA: P/E multiplikatori|Shattuck Labs (STTK) - P/E multiplikatori|EQ (Equillium Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Immunic Inc (IMUX)|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|inflarx.de - Narx-foyda multiplikatori|X4 Pharmaceuticals - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACET (Adicet Bio Inc.)|Celularity Corp - P/E multiplikatori|INMB: Narxning foydaga nisbati|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences Inc)|SABS (SAB Biotherapeutics) - P/E multiplikatori|AKTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENLV|P/E multiplikatori q32bio.com (QTTB)|Narxning foydaga nisbati GeoVax Labs Inc GOVX|Kompaniya qiymatining sof foydaga nisbati EDSA|IBIO - Narxning foydaga nisbati|Carisma Therapeutics (CARM) - Narx-foyda koeffitsiyenti|XTLB: P/E multiplikatori|Bolt Biotherapeutics, Inc. (BOLT) - P/E multiplikatori|Narx-foyda koeffitsiyenti HCWB|APVO: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AIM|Biznesning o‘zini qoplash muddati aditxt.com|Narxning foydaga nisbati GRI Bio GRI|XRTX - Narx-foyda koeffitsiyenti|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics) - Narx-foyda koeffitsiyenti|scinai.com (SCNI) - P/E multiplikatori|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda multiplikatori AFMD (Affimed Therapeutics)|P/E multiplikatori ALLK|HOOK - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori IGMS (IGM Biosciences)|ITOS - Narx-foyda koeffitsiyenti|OCEA - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
